Friday, June 14, 2024

Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft (Marina Temkin/TechCrunch)

Marina Temkin / TechCrunch:
Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft  —  For centuries, people chewed willow tree bark to relieve pain, but scientists at chemical firm Bayer didn't isolate its active ingredient until the 1800s



No comments:

Post a Comment

A profile of Klarna and its CEO Sebastian Siemiatkowski as it filed for a US IPO on November 13; investors hope Klarna can achieve a $150B-$200B valuation (Financial Times)

Financial Times : A profile of Klarna and its CEO Sebastian Siemiatkowski as it filed for a US IPO on November 13; investors hope Klarna ...